DSIP (Delta Sleep-Inducing Peptide) is studied for sleep architecture regulation, HPA axis modulation, and neuroendocrine balance. Physician-reviewed. Prescription required.
DSIP is a naturally occurring neuropeptide primarily studied for its sleep-regulating, stress-modulating, and neuroendocrine effects. It modulates multiple neurotransmitter systems, hormonal axes, and stress-response pathways.
DSIP's effects on sleep architecture, stress hormone regulation, and neuroprotection make it a candidate for physician-supervised sleep optimization and circadian support protocols. Individual outcomes may differ. This protocol is not intended to diagnose, treat, cure, or prevent any disease.
| Mechanism | Biological Effect |
|---|---|
| GABA/glutamate modulation | Promotes slow-wave sleep, relaxation |
| HPA axis regulation | Reduces stress hormone levels |
| Neurotransmitter modulation | Mood stabilization, sleep regulation |
| Neuroprotection & antioxidant effects | Protects neurons from stress |
| Endocrine modulation | Supports GH and hormonal balance |
| Pain pathway modulation | Mild analgesic effects |
Your physician will determine eligibility based on your complete health intake. The following profiles are commonly associated with DSIP protocol candidates in clinical practice:
Sleep Disruption
Individuals with physician-confirmed sleep architecture disruption seeking neuropeptide-based support.
Circadian Dysregulation
Individuals with circadian rhythm disruption where DSIP's neuroendocrine modulation may be clinically relevant.
Stress & HPA Support
Individuals with HPA dysregulation and elevated stress hormone burden.
Recovery Protocol
High-output individuals seeking physician-supervised deep sleep enhancement for recovery.
Determine your candidacy
A physician will review your intake and make eligibility determination within 24–48 hours.
All outcome language below reflects what has been observed in clinical and preclinical settings. Individual outcomes may differ significantly. These are not guarantees.
Dosing is determined individually by your assigned physician. The following represents typical ranges discussed in clinical literature. Do not self-administer or adjust dosing without physician guidance.
Typical Range
25–50 mcg/day
Administration
Subcutaneous or IV (physician-determined)
Duration
2–6 weeks (physician-determined)
Frequency
Once daily (physician-determined)
These ranges are indicative only. Your physician will prescribe the specific dose and schedule appropriate for your clinical profile.
Physician consultation — Virtual intake review and protocol consultation with your assigned NP/MD
Valid prescription — Issued by your attending physician upon protocol approval
Pharmacy-dispensed compound — Dispensed by our licensed 503A compounding pharmacy partner
Follow-up check-in — Physician review at protocol midpoint; reorder pathway established
Your physician will review your complete health history before determining eligibility. The following are commonly reviewed clinical considerations.
Begin your DSIP protocol.
Complete your intake. Physician review within 24–48 hours.
Physician-reviewed. Pharmacy-dispensed. Prescription required before any order is fulfilled.
Prescription required. Results may vary. Individual outcomes may differ.
DSIP is a naturally occurring neuropeptide that promotes deep, restorative sleep, modulates stress hormones, and supports circadian rhythm. It is used for insomnia, sleep optimization, and stress recovery.
DSIP increases delta wave (deep sleep) duration, reduces sleep latency, and helps regulate cortisol and other stress hormones that interfere with sleep quality.
No. DSIP works through natural neuromodulatory pathways and is not habit-forming. It is considered one of the safest sleep-support peptides available.
Yes. DSIP pairs well with CJC-1295/Ipamorelin (both work optimally during deep sleep), sermorelin, and Epithalon for comprehensive sleep and recovery protocols.